Copyright
©The Author(s) 2016.
World J Hepatol. Oct 18, 2016; 8(29): 1244-1250
Published online Oct 18, 2016. doi: 10.4254/wjh.v8.i29.1244
Published online Oct 18, 2016. doi: 10.4254/wjh.v8.i29.1244
Figure 2 This figure shows the trends of gamma-glutamyl transpeptidase, alanine amino-transferase and hepatitis C viremia - RNA during chemotherapies and antiviral therapy.
R: Rituximab; R-CHOP: Cyclophosphamide, doxorubicin, vincristine, prednisolone plus Rituximab; R-DHAP: Cisplatin, cytarabin, dexamethasone plus Rituximab; R-IEV: Ifosfamide, etoposide, epirubicin plus Rituximab; GGT: Gamma-glutamyl transpeptidase; ALT: Alanine amino-transferase; HCV: Hepatitis C viremia.
- Citation: Galati G, Rampa L, Vespasiani-Gentilucci U, Marino M, Pisani F, Cota C, Guidi A, Picardi A. Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy. World J Hepatol 2016; 8(29): 1244-1250
- URL: https://www.wjgnet.com/1948-5182/full/v8/i29/1244.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i29.1244